WO2011043369A1 - 水溶性ポルフィリン及びその製造方法 - Google Patents
水溶性ポルフィリン及びその製造方法 Download PDFInfo
- Publication number
- WO2011043369A1 WO2011043369A1 PCT/JP2010/067530 JP2010067530W WO2011043369A1 WO 2011043369 A1 WO2011043369 A1 WO 2011043369A1 JP 2010067530 W JP2010067530 W JP 2010067530W WO 2011043369 A1 WO2011043369 A1 WO 2011043369A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- water
- group
- integer
- soluble porphyrin
- porphyrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B45/00—Complex metal compounds of azo dyes
- C09B45/02—Preparation from dyes containing in o-position a hydroxy group and in o'-position hydroxy, alkoxy, carboxyl, amino or keto groups
- C09B45/14—Monoazo compounds
- C09B45/16—Monoazo compounds containing chromium
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B69/00—Dyes not provided for by a single group of this subclass
Abstract
Description
1.下記一般式(1)
で示されるテトラフェニルポルフィリン誘導体からなる水溶性ポルフィリン。
2.前記mは、1~9の整数である、上記項1に記載の水溶性ポルフィリン。
3.前記nは、2~3の整数である、上記項1又は2に記載の水溶性ポルフィリン。
4.前記Rは、メチル基、エチル基、ブチル基、ヘキシル基、ドデシル基又はオクタデシル基である、上記項1~3のいずれかに記載の水溶性ポルフィリン。
5.中心金属としてリンを含有するテトラフェニルポルフィリンリン錯体を原料とし、当該錯体に、軸配位子として、下記一般式(2)
-O-(CnH2nO)m-R (2)
〔式中、mは1~30の整数、nは2~4の整数を示す。Rは水素原子、又は置換基を有してもよいアルキル基もしくは芳香族基を示す。〕
で示されるポリアルキレングリコール部位及び置換基(R)を有する配位子を導入する、上記項1に記載の水溶性ポルフィリンの製造方法。
6.光力学的療法における光増感剤として用いる、上記項1~4のいずれかに記載の水溶性ポルフィリン。
本発明の水溶性ポルフィリンは、上記一般式(1)で示されるテトラフェニルポルフィリン誘導体からなることを特徴とする。
本発明の水溶性ポルフィリンの製造方法は限定的ではないが、例えば、中心金属としてリンを含有するテトラフェニルポルフィリンリン錯体を原料とし、当該錯体に、軸配位子として、上記一般式(2)で示される配位子を導入する製造方法(以下、「本発明の製造方法」)が好適に利用できる。以下、これについて説明する。
HO-(CnH2nO)m-R (4)
〔式中、mは1~30の整数、nは2~4の整数を示す。Rは水素原子、又は置換基を有してもよいアルキル基もしくは芳香族基を示す。〕
で示されるポリアルキレングリコール部位及び置換基(R)を有する化合物を反応させて、上記一般式(2)で示される配位子を導入する。
一般式(3)で示される錯体75 mg及び一般式(4)で示される化合物(但し、m=3、n=2、Rはメチル基)10mlをアセトニトリル20 mlに溶解した。
得られたPTPP誘導体 10 mgを水0.50 mlに分散し、3日間放置して飽和水溶液を調製した。水溶液の上澄みを採取し、メタノールで希釈した後、吸収スペクトルを測定し、メタノール中でのPTPP誘導体のモル吸光係数を用いて水への溶解度(Cw)を算出した。ジオキサンについても同様の方法で溶解度(Co)を算出した。
一般式(4)で示される化合物のm、n、Rを表1の通りに変えた以外は、実施例1と同様にしてPTPP誘導体を合成し、溶解度Cw及びCo並びにCadを算出した(表1)。
b) Cad:酵母菌溶液(1.0×104 cell/ml)に10μMのPTPP誘導体を添加した際に菌体に吸着されたPTPP誘導体濃度
c) Nd:検出感度未満
表1の結果から明らかなように、mを1以上に設定することにより、水への溶解度(Cw)を1mM以上に向上させることができる。また、Rをメチル、エチル、ブチル、ヘキシル、ドデシル又はオクタデシルに設定することにより、ジオキサンへの溶解度(Co)を0.1mM以上に向上させることができる。PDT効果が得られる生体親和性の指標となるCadの下限値は特に決定できないが、Cadの下限値は約10 mMである。
Claims (6)
- 前記mは、1~9の整数である、請求項1に記載の水溶性ポルフィリン。
- 前記nは、2~3の整数である、請求項1又は2に記載の水溶性ポルフィリン。
- 前記Rは、メチル基、エチル基、ブチル基、ヘキシル基、ドデシル基又はオクタデシル基である、請求項1~3のいずれかに記載の水溶性ポルフィリン。
- 中心金属としてリンを含有するテトラフェニルポルフィリンリン錯体を原料とし、当該錯体に、軸配位子として、下記一般式(2)
-O-(CnH2nO)m-R (2)
〔式中、mは1~30の整数、nは2~4の整数を示す。Rは水素原子、又は置換基を有してもよいアルキル基もしくは芳香族基を示す。〕
で示されるポリアルキレングリコール部位及び置換基(R)を有する配位子を導入する、請求項1に記載の水溶性ポルフィリンの製造方法。 - 光力学的療法における光増感剤として用いる、請求項1~4のいずれかに記載の水溶性ポルフィリン。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/500,403 US8846904B2 (en) | 2009-10-07 | 2010-10-06 | Water-soluble porphyrin and process for production thereof |
JP2011535418A JP5652791B2 (ja) | 2009-10-07 | 2010-10-06 | 水溶性ポルフィリン及びその製造方法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009233246 | 2009-10-07 | ||
JP2009-233246 | 2009-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011043369A1 true WO2011043369A1 (ja) | 2011-04-14 |
Family
ID=43856822
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2010/067530 WO2011043369A1 (ja) | 2009-10-07 | 2010-10-06 | 水溶性ポルフィリン及びその製造方法 |
Country Status (3)
Country | Link |
---|---|
US (1) | US8846904B2 (ja) |
JP (1) | JP5652791B2 (ja) |
WO (1) | WO2011043369A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015170562A1 (ja) * | 2014-05-08 | 2015-11-12 | 国立大学法人静岡大学 | リンポルフィリン化合物及びその製造方法、並びに生体分子損傷剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2917471B2 (ja) | 1990-09-10 | 1999-07-12 | 剛夫 清水 | ポルフイリン誘導体 |
JPH06220343A (ja) | 1991-03-12 | 1994-08-09 | Takeo Shimizu | ポルフィリン誘導体 |
JP3160999B2 (ja) | 1992-03-09 | 2001-04-25 | 剛夫 清水 | ポルフィリン誘導体およびその製造方法 |
AU2002312154B2 (en) | 2001-06-01 | 2008-05-15 | Biolitec Pharma Marketing Ltd | Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |
JP2008255011A (ja) | 2007-03-30 | 2008-10-23 | Tokyo Metropolitan Univ | 両親媒性金属ポルフィリン錯体、及びそれを用いた医薬組成物 |
-
2010
- 2010-10-06 WO PCT/JP2010/067530 patent/WO2011043369A1/ja active Application Filing
- 2010-10-06 JP JP2011535418A patent/JP5652791B2/ja active Active
- 2010-10-06 US US13/500,403 patent/US8846904B2/en active Active
Non-Patent Citations (3)
Title |
---|
M.HARTMANN ET AL.: "Polymere mit dem Zentralatom eines Makrocyclus in der Hauptkette, 2", MAKROMOLEKULARE CHEMIE, vol. 176, no. 4, 1975, pages 831 - 847 * |
P.C.CHENG ET AL.: "SYNTHESIS AND CHARACTERIZATION OF PHOSPHORUS COMPLEXES OF MESO-TETRAPHENYLPORPHYRIN(tpp), AND X-RAY CRYSTAL STRUCTURE OF [P(tpp)(OCH(CH3) )2]+Cl", POLYHEDRON, vol. 15, no. 16, 1996, pages 2733 - 2740 * |
T.SHIMIDZU ET AL.: "Porphyrin arrays connected with molecular wire", THIN SOLID FILMS, vol. 273, no. 1-2, 1996, pages 14 - 19, XP000624926, DOI: doi:10.1016/0040-6090(95)06764-7 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015170562A1 (ja) * | 2014-05-08 | 2015-11-12 | 国立大学法人静岡大学 | リンポルフィリン化合物及びその製造方法、並びに生体分子損傷剤 |
JPWO2015170562A1 (ja) * | 2014-05-08 | 2017-04-20 | 国立大学法人静岡大学 | リンポルフィリン化合物及びその製造方法、並びに生体分子損傷剤 |
Also Published As
Publication number | Publication date |
---|---|
JP5652791B2 (ja) | 2015-01-14 |
US20120202987A1 (en) | 2012-08-09 |
JPWO2011043369A1 (ja) | 2013-03-04 |
US8846904B2 (en) | 2014-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Patel et al. | Highly effective dual-function near-infrared (NIR) photosensitizer for fluorescence imaging and photodynamic therapy (PDT) of cancer | |
CN100381444C (zh) | 酞菁硅配合物及其复合物以及它们的制备和应用 | |
Yu et al. | Discovery of a monoiodo aza-BODIPY near-infrared photosensitizer: in vitro and in vivo evaluation for photodynamic therapy | |
Lei et al. | Mitochondria-targeting properties and photodynamic activities of porphyrin derivatives bearing cationic pendant | |
EP1966326B1 (en) | Amphiphilic squaraine dyes, process for preparation thereof and use thereof | |
Ravikumar et al. | DNA targeting long-chain alkoxy appended tin (IV) porphyrin scaffolds: photophysical and antimicrobial PDT investigations | |
Donzello et al. | Tetra-2, 3-pyrazinoporphyrazines with externally appended pyridine rings. 9. Novel heterobimetallic macrocycles and related hydrosoluble hexacations as potentially active photo/chemotherapeutic anticancer agents | |
Fagadar-Cosma et al. | Combinatorial synthesis and characterization of new asymmetric porphyrins as potential photosensitizers in photodynamic therapy | |
Hirohara et al. | Sugar and heavy atom effects of glycoconjugated chlorin palladium complex on photocytotoxicity | |
Bonnett et al. | Photobleaching of compounds of the 5, 10, 15, 20-Tetrakis (m-hydroxyphenyl) porphyrin Series (m-THPP, m-THPC, and m-THPBC) | |
CA2323150C (en) | New porphyrins and their use | |
Gayathri et al. | Study on liposomal encapsulation of new bodipy sensitizers for photodynamic therapy | |
Roy et al. | Increased lipophilicity of halogenated ruthenium (II) polypyridyl complexes leads to decreased phototoxicity in vitro when used as photosensitizers for photodynamic therapy | |
Zhang et al. | Synthesis, fluorescence, excited triplet state properties and singlet oxygen generation of para-(tert-butylphenoxy) substituted phthalocyanines containing group IV A central elements | |
CN109796483A (zh) | 一种水溶性阳离子型光敏剂及其制备和应用 | |
Liu et al. | Halogenated gallium corroles: DNA interaction and photodynamic antitumor activity | |
Upadhyay et al. | BODIPY-tagged platinum (II) curcumin complexes for endoplasmic reticulum-targeted red light PDT | |
Karanlık et al. | Comparison of singlet oxygen production of ethyl vanillin substituted silicon phthalocyanine using sonophotodynamic and photodynamic methods | |
Matlou et al. | Evaluation of the photosensitizing properties of zinc and indium tetra cinnamic acid phthalocyanines linked to magnetic nanoparticles on human breast adenocarcinoma cells | |
Castro et al. | Comparison of the photodynamic action of porphyrin, chlorin, and isobacteriochlorin derivatives toward a melanotic cell line | |
Hammer et al. | Charge dependence of cellular uptake and selective antitumor activity of porphyrazines | |
Boscencu et al. | Porphyrin macrocycles: General properties and theranostic potential | |
Ünlü et al. | Synthesis of axially Schiff base new substituted silicon phthalocyanines and investigation of photochemical and sono-photochemical properties | |
RU2621710C1 (ru) | Порфиразин, порфиразиновый комплекс гадолиния и их применение | |
Lazewski et al. | Novel Short PEG Chain-Substituted Porphyrins: Synthesis, Photochemistry, and In Vitro Photodynamic Activity against Cancer Cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10822039 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2011535418 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13500403 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10822039 Country of ref document: EP Kind code of ref document: A1 |